{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:00:46Z","timestamp":1791820846268,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LYY21H300001"],"award-info":[{"award-number":["LYY21H300001"]}]},{"name":"Zhejiang Provincial Health Science and Technology Program","award":["2021KY906"],"award-info":[{"award-number":["2021KY906"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cutaneous melanoma (CM) is a highly malignant tumor originating from melanocytes, and its metastasis and recurrence are the major causes of death in CM patients. PANoptosis is a newly defined inflammatory programmed cell death that crosstalk pyroptosis, apoptosis, and necroptosis. PANoptosis participates in the regulation of tumor progression, especially the expression of PANoptosis related genes (PARGs). Although pyroptosis, apoptosis, and necroptosis have received attention in CM, respectively, the link between them remains elusive. Therefore, this study aimed to investigate the potential regulatory role of PANoptosis and PARGs in CM and the relationship among PANoptosis, PARGs and tumor immunity. We identified 3 PARGs associated with prognosis in CM patients by The Cancer Genome Atlas. Risk model and nomogram were established. Enrichment analysis of differentially expressed genes indicated that CM was immune-related. Subsequent analyses indicated that prognosis-related PARGs were associated with immune scores and infiltration of immune cells in CM patients. In addition, immunotherapy and drug sensitivity results indicated an association between prognosis-related PARGs and drug resistance in CM patients. In conclusion, PARGs play a key role in the progression of tumors in CM patients. PARGs can be used not only for risk assessment and OS prediction in CM patients, but also reflect the immune landscape of CM patients, which can provide a novel reference for individualized tumor treatment.<\/jats:p>","DOI":"10.1038\/s41598-023-35462-4","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T10:02:02Z","timestamp":1685008922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["PANoptosis-related prognostic signature predicts overall survival of cutaneous melanoma and provides insights into immune infiltration landscape"],"prefix":"10.1038","volume":"13","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingde","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"35462_CR1","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3892\/ijo.2018.4287","volume":"52","author":"GC Leonardi","year":"2018","unstructured":"Leonardi, G. C. et al. Cutaneous melanoma: From pathogenesis to therapy (review). Int. J. Oncol. 52, 1071\u20131080. https:\/\/doi.org\/10.3892\/ijo.2018.4287 (2018).","journal-title":"Int. J. Oncol."},{"key":"35462_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"35462_CR3","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1080\/0284186X.2019.1620966","volume":"58","author":"A Arheden","year":"2019","unstructured":"Arheden, A. et al. Real-world data on PD-1 inhibitor therapy in metastatic melanoma. Acta Oncol. 58, 962\u2013966. https:\/\/doi.org\/10.1080\/0284186X.2019.1620966 (2019).","journal-title":"Acta Oncol."},{"key":"35462_CR4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.31128\/AJGP-02-20-5238","volume":"49","author":"VJ Mar","year":"2020","unstructured":"Mar, V. J. et al. Diagnosis and management of cutaneous melanoma. Aust. J. Gen. Pract. 49, 733\u2013739. https:\/\/doi.org\/10.31128\/AJGP-02-20-5238 (2020).","journal-title":"Aust. J. Gen. Pract."},{"key":"35462_CR5","doi-asserted-by":"publisher","first-page":"811","DOI":"10.5858\/arpa.2018-0038-RA","volume":"143","author":"JJ Lee","year":"2019","unstructured":"Lee, J. J. & Lian, C. G. Molecular testing for cutaneous melanoma: An update and review. Arch. Pathol. Lab. Med. 143, 811\u2013820. https:\/\/doi.org\/10.5858\/arpa.2018-0038-RA (2019).","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"Suppl","key":"35462_CR6","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/j.semcancer.2015.03.001","volume":"35","author":"RM Mohammad","year":"2015","unstructured":"Mohammad, R. M. et al. Broad targeting of resistance to apoptosis in cancer. Semin. Cancer Biol. 35(Suppl), S78\u2013S103. https:\/\/doi.org\/10.1016\/j.semcancer.2015.03.001 (2015).","journal-title":"Semin. Cancer Biol."},{"key":"35462_CR7","doi-asserted-by":"publisher","first-page":"11163","DOI":"10.18632\/aging.103528","volume":"12","author":"RKS Malireddi","year":"2020","unstructured":"Malireddi, R. K. S., Tweedell, R. E. & Kanneganti, T. D. PANoptosis components, regulation, and implications. Aging 12, 11163\u201311164. https:\/\/doi.org\/10.18632\/aging.103528 (2020).","journal-title":"Aging"},{"key":"35462_CR8","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/ijc.33698","volume":"149","author":"M Jiang","year":"2021","unstructured":"Jiang, M. et al. Caspase-8: A key protein of cross-talk signal way in \u201cPANoptosis\u201d in cancer. Int. J. Cancer 149, 1408\u20131420. https:\/\/doi.org\/10.1002\/ijc.33698 (2021).","journal-title":"Int. J. Cancer"},{"key":"35462_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fcimb.2020.00238","volume":"10","author":"P Samir","year":"2020","unstructured":"Samir, P., Malireddi, R. K. S. & Kanneganti, T. D. The PANoptosome: A deadly protein complex driving pyroptosis, apoptosis, and necroptosis (PANoptosis). Front. Cell. Infect. Microbiol. 10, 238. https:\/\/doi.org\/10.3389\/fcimb.2020.00238 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"35462_CR10","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.cell.2020.03.040","volume":"181","author":"M Zheng","year":"2020","unstructured":"Zheng, M., Karki, R., Vogel, P. & Kanneganti, T. D. Caspase-6 is a key regulator of innate immunity, inflammasome activation, and host defense. Cell 181, 674\u2013687. https:\/\/doi.org\/10.1016\/j.cell.2020.03.040 (2020).","journal-title":"Cell"},{"key":"35462_CR11","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191644","author":"RKS Malireddi","year":"2020","unstructured":"Malireddi, R. K. S. et al. Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20191644 (2020).","journal-title":"J. Exp. Med."},{"key":"35462_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41586-019-1828-5","volume":"577","author":"N Lalaoui","year":"2020","unstructured":"Lalaoui, N. et al. Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease. Nature 577, 103\u2013108. https:\/\/doi.org\/10.1038\/s41586-019-1828-5 (2020).","journal-title":"Nature"},{"key":"35462_CR13","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.cell.2014.04.019","volume":"157","author":"JA Rickard","year":"2014","unstructured":"Rickard, J. A. et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157, 1175\u20131188. https:\/\/doi.org\/10.1016\/j.cell.2014.04.019 (2014).","journal-title":"Cell"},{"key":"35462_CR14","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1038\/s41467-019-09690-0","volume":"10","author":"Y Dondelinger","year":"2019","unstructured":"Dondelinger, Y. et al. Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation. Nat. Commun. 10, 1729. https:\/\/doi.org\/10.1038\/s41467-019-09690-0 (2019).","journal-title":"Nat. Commun."},{"key":"35462_CR15","doi-asserted-by":"publisher","first-page":"888105","DOI":"10.3389\/fonc.2022.888105","volume":"12","author":"J Huang","year":"2022","unstructured":"Huang, J. et al. Analysis of PANoptosis-related LncRNA-miRNA-mRNA network reveals LncRNA SNHG7 involved in chemo-resistance in colon adenocarcinoma. Front. Oncol. 12, 888105. https:\/\/doi.org\/10.3389\/fonc.2022.888105 (2022).","journal-title":"Front. Oncol."},{"key":"35462_CR16","doi-asserted-by":"publisher","first-page":"109019","DOI":"10.1016\/j.clim.2022.109019","volume":"238","author":"H Pan","year":"2022","unstructured":"Pan, H., Pan, J., Li, P. & Gao, J. Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer. Clin. Immunol. 238, 109019. https:\/\/doi.org\/10.1016\/j.clim.2022.109019 (2022).","journal-title":"Clin. Immunol."},{"key":"35462_CR17","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12967-022-03641-y","volume":"20","author":"L Ren","year":"2022","unstructured":"Ren, L. et al. CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial-mesenchymal transition, G2\/M phase transition, and PANoptosis. J. Transl. Med. 20, 444. https:\/\/doi.org\/10.1186\/s12967-022-03641-y (2022).","journal-title":"J. Transl. Med."},{"key":"35462_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/path.1300","volume":"199","author":"MR Hussein","year":"2003","unstructured":"Hussein, M. R., Haemel, A. K. & Wood, G. S. Apoptosis and melanoma: Molecular mechanisms. J. Pathol. 199, 275\u2013288. https:\/\/doi.org\/10.1002\/path.1300 (2003).","journal-title":"J. Pathol."},{"key":"35462_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/978-0-387-77574-6_22","volume":"624","author":"P Erb","year":"2008","unstructured":"Erb, P., Ji, J., Kump, E., Mielgo, A. & Wernli, M. Apoptosis and pathogenesis of melanoma and nonmelanoma skin cancer. Adv. Exp. Med. Biol. 624, 283\u2013295. https:\/\/doi.org\/10.1007\/978-0-387-77574-6_22 (2008).","journal-title":"Adv. Exp. Med. Biol."},{"key":"35462_CR20","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.1038\/s41598-022-07070-1","volume":"12","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. AC010973.2 promotes cell proliferation and is one of six stemness-related genes that predict overall survival of renal clear cell carcinoma. Sci. Rep. 12, 4272. https:\/\/doi.org\/10.1038\/s41598-022-07070-1 (2022).","journal-title":"Sci. Rep."},{"key":"35462_CR21","doi-asserted-by":"publisher","first-page":"11926","DOI":"10.1038\/s41598-021-90112-x","volume":"11","author":"L Yu","year":"2021","unstructured":"Yu, L. et al. Multi-omics analysis reveals the interaction between the complement system and the coagulation cascade in the development of endometriosis. Sci. Rep. 11, 11926. https:\/\/doi.org\/10.1038\/s41598-021-90112-x (2021).","journal-title":"Sci. Rep."},{"key":"35462_CR22","doi-asserted-by":"publisher","first-page":"8069","DOI":"10.1038\/s41598-021-87540-0","volume":"11","author":"D Wu","year":"2021","unstructured":"Wu, D. et al. Identification of novel autophagy-related lncRNAs associated with a poor prognosis of colon adenocarcinoma through bioinformatics analysis. Sci. Rep. 11, 8069. https:\/\/doi.org\/10.1038\/s41598-021-87540-0 (2021).","journal-title":"Sci. Rep."},{"key":"35462_CR23","doi-asserted-by":"publisher","first-page":"107327482211294","DOI":"10.1177\/10732748221129451","volume":"29","author":"D Zhang","year":"2022","unstructured":"Zhang, D. et al. Prognostic role of DNA damage response genes mutations and their association with the sensitivity of olaparib in prostate cancer patients. Cancer Control J. Moffitt Cancer Center 29, 10732748221129452. https:\/\/doi.org\/10.1177\/10732748221129451 (2022).","journal-title":"Cancer Control J. Moffitt Cancer Center"},{"key":"35462_CR24","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","volume":"383","author":"AM Eggermont","year":"2014","unstructured":"Eggermont, A. M., Spatz, A. & Robert, C. Cutaneous melanoma. Lancet 383, 816\u2013827. https:\/\/doi.org\/10.1016\/S0140-6736(13)60802-8 (2014).","journal-title":"Lancet"},{"key":"35462_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-021-03875-8","volume":"597","author":"S Lee","year":"2021","unstructured":"Lee, S. et al. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. Nature 597, 415\u2013419. https:\/\/doi.org\/10.1038\/s41586-021-03875-8 (2021).","journal-title":"Nature"},{"key":"35462_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cells11091495","author":"JM Gullett","year":"2022","unstructured":"Gullett, J. M., Tweedell, R. E. & Kanneganti, T. D. It\u2019s all in the PAN: Crosstalk, plasticity, redundancies, switches, and interconnectedness encompassed by PANoptosis underlying the totality of cell death-associated biological effects. Cells. https:\/\/doi.org\/10.3390\/cells11091495 (2022).","journal-title":"Cells."},{"key":"35462_CR27","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.136720","author":"R Karki","year":"2020","unstructured":"Karki, R. et al. Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.136720 (2020).","journal-title":"JCI Insight."},{"key":"35462_CR28","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.cell.2021.01.018","volume":"184","author":"CR Glassman","year":"2021","unstructured":"Glassman, C. R. et al. Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells. Cell 184, 983\u2013999. https:\/\/doi.org\/10.1016\/j.cell.2021.01.018 (2021).","journal-title":"Cell"},{"key":"35462_CR29","doi-asserted-by":"publisher","first-page":"2057399","DOI":"10.1080\/2162402X.2022.2057399","volume":"11","author":"H Deng","year":"2022","unstructured":"Deng, H. et al. Translocation of Helicobacter hepaticus synergizes with myeloid-derived suppressor cells and contributes to breast carcinogenesis. Oncoimmunology 11, 2057399. https:\/\/doi.org\/10.1080\/2162402X.2022.2057399 (2022).","journal-title":"Oncoimmunology"},{"key":"35462_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0378-1119(99)00419-9","volume":"240","author":"Y Fu","year":"1999","unstructured":"Fu, Y. et al. Cloning of DLM-1, a novel gene that is up-regulated in activated macrophages, using RNA differential display. Gene 240, 157\u2013163. https:\/\/doi.org\/10.1016\/s0378-1119(99)00419-9 (1999).","journal-title":"Gene"},{"key":"35462_CR31","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.chom.2016.09.014","volume":"20","author":"RJ Thapa","year":"2016","unstructured":"Thapa, R. J. et al. DAI senses influenza A virus genomic RNA and activates RIPK3-dependent cell death. Cell Host Microbe 20, 674\u2013681. https:\/\/doi.org\/10.1016\/j.chom.2016.09.014 (2016).","journal-title":"Cell Host Microbe"},{"key":"35462_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aag2045","author":"T Kuriakose","year":"2016","unstructured":"Kuriakose, T. et al. ZBP1\/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci. Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.aag2045 (2016).","journal-title":"Sci. Immunol."},{"key":"35462_CR33","doi-asserted-by":"publisher","first-page":"109858","DOI":"10.1016\/j.celrep.2021.109858","volume":"37","author":"R Karki","year":"2021","unstructured":"Karki, R. et al. ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis. Cell Rep. 37, 109858. https:\/\/doi.org\/10.1016\/j.celrep.2021.109858 (2021).","journal-title":"Cell Rep."},{"key":"35462_CR34","doi-asserted-by":"publisher","first-page":"eabf6290","DOI":"10.1126\/sciadv.abf6290","volume":"7","author":"Y Yang","year":"2021","unstructured":"Yang, Y. et al. ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation. Sci. Adv. 7, eabf6290. https:\/\/doi.org\/10.1126\/sciadv.abf6290 (2021).","journal-title":"Sci. Adv."},{"key":"35462_CR35","doi-asserted-by":"publisher","first-page":"14231","DOI":"10.1073\/pnas.2005353117","volume":"117","author":"S Tan","year":"2020","unstructured":"Tan, S. et al. Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma. Proc. Natl. Acad. Sci. U.S.A. 117, 14231\u201314242. https:\/\/doi.org\/10.1073\/pnas.2005353117 (2020).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"35462_CR36","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1073\/pnas.0909781107","volume":"107","author":"S Inokuchi","year":"2010","unstructured":"Inokuchi, S. et al. Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 107, 844\u2013849. https:\/\/doi.org\/10.1073\/pnas.0909781107 (2010).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"35462_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fcell.2016.00021","volume":"4","author":"E Richter","year":"2016","unstructured":"Richter, E., Ventz, K., Harms, M., Mostertz, J. & Hochgrafe, F. Induction of macrophage function in human THP-1 cells is associated with rewiring of MAPK signaling and activation of MAP3K7 (TAK1) protein kinase. Front. Cell Dev. Biol. 4, 21. https:\/\/doi.org\/10.3389\/fcell.2016.00021 (2016).","journal-title":"Front. Cell Dev. Biol."},{"key":"35462_CR38","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1172\/JCI128075","volume":"130","author":"EY Kim","year":"2020","unstructured":"Kim, E. Y. et al. Post-sepsis immunosuppression depends on NKT cell regulation of mTOR\/IFN-gamma in NK cells. J. Clin. Investig. 130, 3238\u20133252. https:\/\/doi.org\/10.1172\/JCI128075 (2020).","journal-title":"J. Clin. Investig."},{"key":"35462_CR39","doi-asserted-by":"publisher","first-page":"734646","DOI":"10.3389\/fimmu.2021.734646","volume":"12","author":"W Xu","year":"2021","unstructured":"Xu, W. et al. Comprehensive multi-omics identification of interferon-gamma response characteristics reveals that RBCK1 regulates the immunosuppressive microenvironment of renal cell carcinoma. Front. Immunol. 12, 734646. https:\/\/doi.org\/10.3389\/fimmu.2021.734646 (2021).","journal-title":"Front. Immunol."},{"key":"35462_CR40","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41419-019-1488-2","volume":"10","author":"S Yu","year":"2019","unstructured":"Yu, S. et al. RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma. Cell Death Dis. 10, 254. https:\/\/doi.org\/10.1038\/s41419-019-1488-2 (2019).","journal-title":"Cell Death Dis."},{"key":"35462_CR41","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s00415-017-8710-x","volume":"265","author":"M Krenn","year":"2018","unstructured":"Krenn, M. et al. Mutations outside the N-terminal part of RBCK1 may cause polyglucosan body myopathy with immunological dysfunction: Expanding the genotype-phenotype spectrum. J. Neurol. 265, 394\u2013401. https:\/\/doi.org\/10.1007\/s00415-017-8710-x (2018).","journal-title":"J. Neurol."},{"key":"35462_CR42","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12964-022-00963-8","volume":"20","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo\/YAP axis. Cell Commun. Signal 20, 164. https:\/\/doi.org\/10.1186\/s12964-022-00963-8 (2022).","journal-title":"Cell Commun. Signal"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35462-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35462-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35462-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T10:03:25Z","timestamp":1685009005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35462-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["35462"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-35462-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,25]]},"assertion":[{"value":"19 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8449"}}